Development and Evaluation of AccuPower® COVID-19 Kit
for SARS-CoV-2 Detection in Sputum and NPS/OPS, Saliva, and Pooled Samples.
Speech by MoonJung KIM
Rapid and accurate detection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for successfully controlling the current global COVID-19 pandemic.
We will cover our AccuPower® COVID-19 Kits compare to the current standard confirmation assay and the suitability to effective clinical management and control of SARS-CoV-2.
“Twindemic” means COVID-19 and the flu peak at the same time.
Flu and COVID-19 have similar symptoms, but their causes and treatments are different. For preventing the spread of COVID-19, we need to distinguish between Flu and COVID-19 accurately. Molecular diagnostics is the best way to distinguish between flu and COVID-19. BIONEER provides a molecular diagnostic total solution for COVID-19 prevention.
To find more about our Diagnosis test kits: https://eng.bioneer.com/c-diagnostic.html